Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul-Aug;35(4):2127-2134.
doi: 10.21873/invivo.12482.

Integrin α5β1 Mediated Cellular Reorganization in Human Mesenchymal Stem Cells During Neuronal Differentiation

Affiliations

Integrin α5β1 Mediated Cellular Reorganization in Human Mesenchymal Stem Cells During Neuronal Differentiation

Nihal Karakaş et al. In Vivo. 2021 Jul-Aug.

Abstract

Background/aim: Mesenchymal stem cells (MSCs) have been widely used for yielding neurons in culture to study nervous system pathologies and develop regenerative approaches. In this study, cellular rearrangements of human MSCs related to the expression of the fibronectin common receptor integrin α5β1 and its cell surface localization during neuronal differentiation, were examined.

Materials and methods: Proliferation kinetics of neuronal induced hMSCs (hMd-Neurons) were quantified by BrdU assay, and hMd-Neurons were immunostained for neuronal marker expression. Additionally, cDNA and protein samples were collected at different time points for integrin α5β1 expression analysis.

Results: Endogenous integrin α5β1 expression was significantly upregulated by day 6 and maintained until day 12. Cell surface localization of α5β1 integrin was increased by day 6; the integrin was internalized into the cytosol by day 12.

Conclusion: Integrin dynamics around day 6 of differentiation might be involved in neuronal differentiation and maturation or specification of hMd-Neurons.

Keywords: Mesenchymal stem cells; integrin; integrin α5β1; neuronal differentiation.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest in relation to this study.

Figures

Figure 1
Figure 1. Derivation of neurons from hMSCs (hMd-Neurons). A) hMSC immunophenotyping by flow cytometry shows that cells are positive for MSC markers CD44, CD73, CD90, and CD105 while lacking hematopoietic lineage markers CD34 and CD45. B) Bright field images of hMd-Neurons and uninduced hMSCs (40×). C) Immunoflourescence images of NeuN and Neurofilament (NF) in hMd-Neurons at day 12 (40×). D) Caspase 3 assay for induced, uninduced hMSCs as well as CAM treated (apoptosis inducer; positive control) and Z-DEVD-FMK treated (apoptosis inhibitor; negative control) hMSCs at days 2-12. CAM treated hMSCs show significant caspase 3 activity. Data represent mean±SE; p<0.0001.
Figure 2
Figure 2. Cellular rearrangements during hMSC differentiation into neurons. A) BrdU assay showing that hMSC proliferation decreases by neuronal differentiation within 48 h after neuronal induction. B) Florescent images of DAPI staining in uninduced hMSCs and hMd-Neurons (40×). Data represents mean±SE. C) Violin plot indicating changes in nucleus diameter in hMSCs when reaching day 12 of neuronal differentiation. Each dot represents a single cell. Plot width is proportional to cell frequency at a given diameter. p<0.001 and p<0.0001 using Welch’s t-test.
Figure 3
Figure 3. Integrin α5β1 expression dynamics of hMd-Neurons. A) Transcripts of α5 and β1 in hMSCs and hMd-Neurons at day 12. B) Endogenous protein expression levels of integrin α5β1 and C-E) fluorescent images of integrin α5β1 localization during neuronal differentiation of hMSCs. F) Plots indicate percentage of integrin α5β1 cell surface localization among stained cells at days 2, 6, and 12 of differentiation. One hundred cells from three different regions were counted and data represent mean±SE, p<0.001.

Similar articles

Cited by

References

    1. Kimbrel EA, Lanza R. Next-generation stem cells - ushering in a new era of cell-based therapies. Nat Rev Drug Discov. 2020;19(7):463–479. doi: 10.1038/s41573-020-0064-x. - DOI - PubMed
    1. Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng. 2019;3(2):90–104. doi: 10.1038/s41551-018-0325-8. - DOI - PubMed
    1. Kadereit S, Deeds LS, Haynesworth SE, Koc ON, Kozik MM, Szekely E, Daum-Woods K, Goetchius GW, Fu P, Welniak LA, Murphy WJ, Laughlin MJ. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer. Stem Cells. 2002;20(6):573–582. doi: 10.1634/stemcells.20-6-573. - DOI - PubMed
    1. Nancarrow-Lei R, Mafi P, Mafi R, Khan W. A systemic review of adult mesenchymal stem cell sources and their multilineage differentiation potential relevant to musculoskeletal tissue repair and regeneration. Curr Stem Cell Res Ther. 2017;12(8):601–610. doi: 10.2174/1574888X12666170608124303. - DOI - PubMed
    1. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403. doi: 10.1111/j.1365-2184.1970.tb00347.x. - DOI - PubMed

Substances

LinkOut - more resources